SeaBeLife
Latest round
- Seed
Last raised
- Sep 2023
Total raised
- $2.5M
Investors
- 6
About SeaBeLife
The company was founded by its CEO, Morgane Rousselot, Stéphane Bach, Marie-Thérèse Dimanche-Boitrel, and CTO, Claire Delehouzé. SeaBeLife develops patentable candidate compounds to cure necroptosis and ferroptosis, two types of cell death diseases, by deprogramming controlled cell death in the patient to protect or regenerate organs damaged by pathologies., regulated cell death), which is the primary cause of disorders affecting major organs such as the acute liver (acute hepatic failure) and kidney (acute renal failure). The company conducts research on degenerative and ocular disorders (Parkinson's disease, AMD, and so on) as of 2022.
Who invested in SeaBeLife
6 investors across 2 rounds
See all investors in SeaBeLife
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SeaBeLife
Who invested in SeaBeLife?
SeaBeLife has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SeaBeLife raised?
SeaBeLife has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SeaBeLife last raise money?
SeaBeLife's most recent round on record is a Seed, in Sep 2023.
What does SeaBeLife do?
The company was founded by its CEO, Morgane Rousselot, Stéphane Bach, Marie-Thérèse Dimanche-Boitrel, and CTO, Claire Delehouzé.
Where is SeaBeLife headquartered?
SeaBeLife is headquartered in Roscoff, France.
Which VCs invest in companies like SeaBeLife?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at SeaBeLife's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like SeaBeLife? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.